<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03384953</url>
  </required_header>
  <id_info>
    <org_study_id>170652</org_study_id>
    <nct_id>NCT03384953</nct_id>
  </id_info>
  <brief_title>Chronic Pain Skills Study - Vanderbilt University Medical Center</brief_title>
  <official_title>Chronic Pain Skills Study - Vanderbilt University Medical Center</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Osher Center for Integrative Medicine (OCIM) at Vanderbilt is a multidisciplinary&#xD;
      outpatient clinic treating patients with chronic pain and complex health issues via&#xD;
      integrative services, with goals of improving overall health and wellbeing of those served.&#xD;
      At OCIM, clinical hypnosis has been historically provided on an individual basis by the&#xD;
      investigator. Due to its impact and increased patient demand for this service, the&#xD;
      investigator will be conducting group hypnosis services in addition to individual services&#xD;
      order to expand the reach of this program to participants. As such, the investigators see&#xD;
      this as a tremendous opportunity to contribute to clinical research to contribute to the&#xD;
      evidence based for this form of service by examining participant-reported outcomes associated&#xD;
      with completing the treatment. For this project, the investigators seek to assess the impact&#xD;
      of a manualized group treatment protocol utilizing clinical hypnosis as a treatment for&#xD;
      chronic pain. The investigators will be evaluating participant-reported outcomes to assess&#xD;
      the feasibility of conducting hypnosis in this setting, impact of group hypnosis on pain and&#xD;
      how participants' responsiveness to hypnosis impacts treatment outcome.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this pilot project is to test the efficacy and mechanisms of clinical hypnosis&#xD;
      on chronic pain. Primary (characteristic pain intensity) and secondary (mood, quality of&#xD;
      life) outcomes will be assessed at pre-treatment, three times during treatment,&#xD;
      post-treatment, and at 3- and 6-month follow-up. Potential treatment moderators and mediators&#xD;
      will also be assessed. The study will address two aims:&#xD;
&#xD;
      Aim 1: Determine the efficacy of 8 sessions of group delivered HYP training for reducing&#xD;
      characteristic pain intensity in patients. The hypothesis associated with Aim 1 is:&#xD;
&#xD;
      Hypothesis 1: Primary Study Hypothesis. Patients receiving 8 sessions of HYP training will&#xD;
      report significantly reduced pre- to post-treatment decreases in average pain intensity.&#xD;
&#xD;
      Aim 2 : To evaluate potential moderators (hypnotizability) associated with treatment outcomes&#xD;
      following intervention. The hypothesis associated with Aim 2 is:&#xD;
&#xD;
      Hypothesis 2a: Hypnotizability will augment treatment outcomes such that those with higher&#xD;
      hypnotizability will experience significantly greater treatment gains.&#xD;
&#xD;
      In addition to testing the above specific hypotheses, we will use the data obtained in this&#xD;
      study to further explore (1) the longer-term (up to 6 months) effects of HYP and (2)&#xD;
      additional potential moderators (e.g., treatment outcome expectancies, treatment motivation,&#xD;
      demographic variables, pain type [neuropathic vs. nociceptive]) and mediators (pain&#xD;
      acceptance, catastrophizing, mindfulness, therapeutic alliance, amount of skill practice&#xD;
      between sessions) of treatment outcome.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 22, 2017</start_date>
  <completion_date type="Actual">March 13, 2020</completion_date>
  <primary_completion_date type="Actual">February 13, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Pain Intensity</measure>
    <time_frame>baseline and 6 months</time_frame>
    <description>Brief Pain Inventory (severity scale only) is a 4-item subscale of the Brief Pain Inventory assessing the severity of pain over the past week. Questions inquire into an individual's worst, least, average, and current levels of pain on an 11-point likert scale, with 0 being no pain. It has been validated and is considered the gold standard to utilize in patient-reported outcomes studies. It takes &lt;1 minute to complete.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">103</enrollment>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Clinical Hypnosis - Group Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive 8 weeks of a manualized clinical hypnosis for chronic pain treatment in a group setting. Assessments will be completed before, immediately after, and at 3- and 6- months post-treatment to assess for treatment gains.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clinical Hypnosis - Individual Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive 8 weeks of a manualized clinical hypnosis for chronic pain treatment in an individual, 1:1 setting. Assessments will be completed before, immediately after, and at 3- and 6- months post-treatment to assess for treatment gains.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Clinical Hypnosis - Group Treatment</intervention_name>
    <description>group treatment</description>
    <arm_group_label>Clinical Hypnosis - Group Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Clinical Hypnosis - Individual Treatment</intervention_name>
    <description>individual treatment</description>
    <arm_group_label>Clinical Hypnosis - Individual Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. 18 years of age or older; *&#xD;
&#xD;
          2. Self-reported presence of chronic pain;**&#xD;
&#xD;
          3. Average pain intensity rating of ≥ 3 on a 0-10 Numerical Rating Scale (NRS) of pain&#xD;
             intensity in the last week; **&#xD;
&#xD;
          4. Worst pain intensity rating of ≥ 5 on a 0-10 Numerical Rating Scale (NRS) of pain&#xD;
             intensity in the last week;**&#xD;
&#xD;
          5. Duration of chronic pain 3 months or more; **&#xD;
&#xD;
          6. Experiences pain at least 75% of the time in the past 3 months; Those who have a hard&#xD;
             time answering this question will be asked the following question: &quot;Which statement&#xD;
             best describes your pain?&quot;&#xD;
&#xD;
               1. Pain all the time, but the pain intensity varies;&#xD;
&#xD;
               2. Pain most of the time with only occasional periods of being pain-free;&#xD;
&#xD;
               3. Pain that comes and goes;&#xD;
&#xD;
               4. Occasional pain; Participants must report experiencing pain that matches one of&#xD;
                  the first two options;**&#xD;
&#xD;
          7. Able to read, speak, and understand English.**&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Cognitive impairment or limitations (i.e. history of moderate to severe Traumatic&#xD;
             Brain Injury (TBI), unresolved TBI, or other medical condition) that would interfere&#xD;
             with a patient's ability to participate in a group involving focused attention*.&#xD;
&#xD;
          2. Current or history of diagnosis of primary psychotic or major thought disorder as&#xD;
             listed in participant's medical record or self-reported within the past five years;*&#xD;
&#xD;
          3. Hospitalization for psychiatric reasons other than suicidal ideation, homicidal&#xD;
             ideation, and/or PTSD self-reported or noted in chart (within the past 5 years);*&#xD;
&#xD;
          4. Psychiatric or behavioral conditions in which symptoms are unstable or severe (e.g.&#xD;
             current delirium, mania, psychosis, suicidal ideation, homicidal ideation, substance&#xD;
             abuse dependency) as listed in participant's medical record or self-reported within&#xD;
             the past six months;*&#xD;
&#xD;
          5. Any behavioral issues as noted in the medical record or by a provider that would&#xD;
             indicate the participant may be inappropriate in a group setting;***&#xD;
&#xD;
          6. Presenting symptoms at time of screening that would interfere with participation,&#xD;
             specifically active suicidal ideation with intent to harm oneself or active delusional&#xD;
             or psychotic thinking;**&#xD;
&#xD;
          7. Difficulties or limitations communicating over the telephone;**&#xD;
&#xD;
          8. Any planned life events that would interfere with participating in the key elements of&#xD;
             the study.**&#xD;
&#xD;
          9. Reported average daily use of &gt;120mg morphine equivalent dose (MED). **&#xD;
&#xD;
               -  also verified via medical record review, as described below. **verified solely&#xD;
                  via self-report, as described below; there is no medical record&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lindsey C McKernan, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Osher Center for Integrative Medicine at Vanderbilt</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>December 20, 2017</study_first_submitted>
  <study_first_submitted_qc>December 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 28, 2017</study_first_posted>
  <results_first_submitted>April 6, 2020</results_first_submitted>
  <results_first_submitted_qc>April 13, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">April 21, 2020</results_first_posted>
  <last_update_submitted>April 13, 2020</last_update_submitted>
  <last_update_submitted_qc>April 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Lindsey Mckernan</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 10, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/53/NCT03384953/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>August 1, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/53/NCT03384953/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Clinical Hypnosis - Group Treatment</title>
          <description>Subjects will receive 8 weeks of a manualized clinical hypnosis for chronic pain treatment in a group setting. Assessments will be completed before, immediately after, and at 3- and 6- months post-treatment to assess for treatment gains.&#xD;
Clinical Hypnosis - Group Treatment: group treatment</description>
        </group>
        <group group_id="P2">
          <title>Clinical Hypnosis - Individual Treatment</title>
          <description>Subjects will receive 8 weeks of a manualized clinical hypnosis for chronic pain treatment in an individual, 1:1 setting. Assessments will be completed before, immediately after, and at 3- and 6- months post-treatment to assess for treatment gains.&#xD;
Clinical Hypnosis - Individual Treatment: individual treatment</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="91"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Completed Treatment</title>
              <participants_list>
                <participants group_id="P1" count="68"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Clinical Hypnosis - Group Treatment</title>
          <description>Subjects will receive 8 weeks of a manualized clinical hypnosis for chronic pain treatment in a group setting. Assessments will be completed before, immediately after, and at 3- and 6- months post-treatment to assess for treatment gains.&#xD;
Clinical Hypnosis - Group Treatment: group treatment</description>
        </group>
        <group group_id="B2">
          <title>Clinical Hypnosis - Individual Treatment</title>
          <description>Subjects will receive 8 weeks of a manualized clinical hypnosis for chronic pain treatment in an individual, 1:1 setting. Assessments will be completed before, immediately after, and at 3- and 6- months post-treatment to assess for treatment gains.&#xD;
Clinical Hypnosis - Individual Treatment: individual treatment</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="91"/>
            <count group_id="B2" value="12"/>
            <count group_id="B3" value="103"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51.196" spread="13.894"/>
                    <measurement group_id="B2" value="44.833" spread="13.402"/>
                    <measurement group_id="B3" value="50.462" spread="13.925"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="65"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="74"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="75"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="85"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="91"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="103"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Brief Pain Inventory</title>
          <description>Higher values indicate worse pain and possible scale values range from 0 to 10.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.472" spread="1.736"/>
                    <measurement group_id="B2" value="6.125" spread="1.721"/>
                    <measurement group_id="B3" value="5.549" spread="1.739"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Pain Intensity</title>
        <description>Brief Pain Inventory (severity scale only) is a 4-item subscale of the Brief Pain Inventory assessing the severity of pain over the past week. Questions inquire into an individual's worst, least, average, and current levels of pain on an 11-point likert scale, with 0 being no pain. It has been validated and is considered the gold standard to utilize in patient-reported outcomes studies. It takes &lt;1 minute to complete.</description>
        <time_frame>baseline and 6 months</time_frame>
        <population>Patients who completed 6-month post-treatment follow-up</population>
        <group_list>
          <group group_id="O1">
            <title>Clinical Hypnosis - Group Treatment</title>
            <description>Subjects will receive 8 weeks of a manualized clinical hypnosis for chronic pain treatment in a group setting. Assessments will be completed before, immediately after, and at 3- and 6- months post-treatment to assess for treatment gains.&#xD;
Clinical Hypnosis - Group Treatment: group treatment</description>
          </group>
          <group group_id="O2">
            <title>Clinical Hypnosis - Individual Treatment</title>
            <description>Subjects will receive 8 weeks of a manualized clinical hypnosis for chronic pain treatment in an individual, 1:1 setting. Assessments will be completed before, immediately after, and at 3- and 6- months post-treatment to assess for treatment gains.&#xD;
Clinical Hypnosis - Individual Treatment: individual treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Pain Intensity</title>
          <description>Brief Pain Inventory (severity scale only) is a 4-item subscale of the Brief Pain Inventory assessing the severity of pain over the past week. Questions inquire into an individual's worst, least, average, and current levels of pain on an 11-point likert scale, with 0 being no pain. It has been validated and is considered the gold standard to utilize in patient-reported outcomes studies. It takes &lt;1 minute to complete.</description>
          <population>Patients who completed 6-month post-treatment follow-up</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.42" spread="2.173"/>
                    <measurement group_id="O2" value="6.625" spread="1.422"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 months (during 8-session treatment)</time_frame>
      <desc>In accordance with federal regulations and VUMC policy, adverse events and unanticipated problems involving risk to participants or others that fall under VUMC IRB jurisdiction were reported to the VUMC IRB within 10 working days after learning of the event or problem.</desc>
      <group_list>
        <group group_id="E1">
          <title>Clinical Hypnosis - Group Treatment</title>
          <description>Subjects will receive 8 weeks of a manualized clinical hypnosis for chronic pain treatment in a group setting. Assessments will be completed before, immediately after, and at 3- and 6- months post-treatment to assess for treatment gains.&#xD;
Clinical Hypnosis - Group Treatment: group treatment</description>
        </group>
        <group group_id="E2">
          <title>Clinical Hypnosis - Individual Treatment</title>
          <description>Subjects will receive 8 weeks of a manualized clinical hypnosis for chronic pain treatment in an individual, 1:1 setting. Assessments will be completed before, immediately after, and at 3- and 6- months post-treatment to assess for treatment gains.&#xD;
Clinical Hypnosis - Individual Treatment: individual treatment</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Lindsey C. McKernan</name_or_title>
      <organization>Osher Center for Integrative Medicine</organization>
      <phone>615-320-7770</phone>
      <email>lindsey.mckernan@vumc.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

